AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
14min chapter
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Hematologic Oncology Update
Various Drug Therapies for AML and MDS
The chapter explores the use and efficacy of different drugs, including quizartinib and guilt rittinib, in treating patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). They discuss the duration of response to single agent guilt rittinib and the potential benefits of combining venetoclax with guilt rittinib. Furthermore, they analyze the outcomes of a recently approved frontline flip three inhibitor, quizartinib.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode